Securities Registration (section 12(b)) (8-a12b)
July 08 2016 - 7:47AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES
OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g)
OF THE
SECURITIES EXCHANGE ACT OF 1934
DELMAR PHARMACEUTICALS, INC.
(Exact name of registrant as specified
in its charter)
Nevada
|
|
99-0360497
|
(State of incorporation or organization)
|
|
(IRS
Employer Identification No.)
|
Suite 720-999 West Broadway
Vancouver, British Columbia
Canada V5Z 1K5
(Address of principal executive
offices) (Zip Code)
Securities to be registered pursuant to Section 12(b) of
the Act:
Title of each class to
be registered: Common Stock, par value $0.001 per share
Name of each exchange on which each class is to be registered: The
NASDAQ Stock Market LLC
If this Form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. ☒
|
|
If this Form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box.
o
|
Securities Act registration statement file number to which
this form relates: _______ (if applicable)
Securities to be registered pursuant to Section 12(g) of
the Act: None.
Item 1. Description of Registrant's Securities
to be Registered.
The description of the common stock of DelMar
Pharmaceuticals, Inc. (the “Registrant”), as included under the caption “Description of Securities” in
the prospectus forming a part of the Post-Effective Amendment No. 3 to Registration Statement on Form S-1 (Registration No. 333-189337)
(the “Registration Statement”), filed under the Securities Act of 1933, as amended (the “Securities Act”),
is incorporated by reference herein. In addition, any description of such securities contained in a form of prospectus relating
to the Registration Statement subsequently filed by the Registrant pursuant to Rule 424(b) under the Securities Act shall be deemed
to be incorporated by reference herein.
Item 2. Exhibits.
Under the Instructions as to Exhibits with
respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The NASDAQ
Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities
Exchange Act of 1934, as amended.
SIGNATURE
Pursuant to the requirements of Section
12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf
by the undersigned, thereto duly authorized.
|
DELMAR PHARMACEUTICALS, INC.
|
|
|
|
Date: July
7, 2016
|
By:
|
/s/ Jeffrey Bacha
|
|
|
Name: Jeffrey Bacha
|
|
|
Title: Chief Executive Officer
|
DelMar Pharmaceuticals (NASDAQ:DMPI)
Historical Stock Chart
From Mar 2024 to Apr 2024
DelMar Pharmaceuticals (NASDAQ:DMPI)
Historical Stock Chart
From Apr 2023 to Apr 2024